These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Author: Markovitz PJ, Stagno SJ, Calabrese JR.
    Journal: Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516.
    Abstract:
    Eleven obsessive-compulsive patients underwent a prospective open-label trial of fluoxetine monotherapy followed by buspirone augmentation. The combination therapy was statistically superior to fluoxetine monotherapy. The results point to the importance of the 5-HT1a receptor in obsessive-compulsive disorder.
    [Abstract] [Full Text] [Related] [New Search]